Treace Medical Concepts Inc (United States) is listed on the Nasdaq and has a market capitalization of $308.10 million, with shareholders equity totaling $67.74 million.
The Company is listed on the [MARKET_NAME]
Over the past 12 months, Treace Medical Concepts Inc reported $205.31 million in revenue, generating net income of $-59.51 million.
Key financial metrics include a P/E ratio of -5.18, a price-to-book (P/B) ratio of 4.55, and a trailing twelve-month dividend yield of 0.00%.
The company trades under the ticker TMCI.